|
|
|
|
| LEADER |
07121nam a2200577 a 4500 |
| 001 |
26657 |
| 003 |
BD-DhAAL |
| 008 |
130210r20111991paua b 001 0 eng d |
| 010 |
|
|
|a 90005614
|
| 020 |
|
|
|a 9788188449064
|
| 020 |
|
|
|a 8188449067
|
| 020 |
|
|
|a 0812113462
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d BD-DhAAL
|
| 082 |
0 |
0 |
|a 615.7
|
| 100 |
1 |
|
|a Gibaldi, Milo.
|9 44109
|
| 245 |
1 |
0 |
|a Biopharmaceutics and clinical pharmacokinetics /
|c Milo Gibaldi.
|
| 250 |
|
|
|a Fourth edition.
|
| 260 |
|
|
|a Philadelphia :
|b Lea & Febiger ;
|a Hyderabad :
|b PharmaMed Press,
|c 1991 [reprinted 2011, 2023, 2025].
|
| 300 |
|
|
|a x, 406 pages :
|b illustrations ;
|c 27 cm
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 526 |
|
|
|a PHR
|x Dr. Hasina Jesmin,
Assistant Dean and Program Director
Course name : Biopharmaceutics & Pharmacokinetics I and II (PHR 304 and PHR 313).
|
| 541 |
1 |
|
|a Hye Trade International
|e 26657, 43657, 43658, 43659, 43660, 43661, 43682, 43683, 43684, 43685, 43686, 43687, 43789, 43790, 43791, 43792
|
| 650 |
|
0 |
|a Biopharmaceutics.
|9 44110
|
| 650 |
|
0 |
|a Pharmacokinetics.
|9 44111
|
| 650 |
|
2 |
|a Biopharmaceutics.
|9 44110
|
| 650 |
|
2 |
|a Pharmacokinetics.
|9 44111
|
| 650 |
|
2 |
|a Pharmacology.
|
| 650 |
|
2 |
|a Pharmacy.
|
| 852 |
1 |
|
|a Ayesha Abed Library
|c General Stacks
|
| 942 |
|
|
|2 ddc
|c BK
|
| 999 |
|
|
|c 13175
|d 13175
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_GIB
|7 0
|9 21933
|a BRACUL
|b BRACUL
|c GEN
|d 2013-02-10
|e Karim International
|g 638.00
|l 2
|m 13
|o 615.7 GIB
|p 3010026657
|r 2024-01-28
|s 2024-01-24
|t 1
|w 2013-02-10
|y BK
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_GIB
|7 0
|9 21934
|a BRACUL
|b BRACUL
|c GEN
|d 2013-02-10
|e Karim International
|g 638.00
|l 4
|m 47
|o 615.7 GIB
|p 3010026658
|r 2024-03-04
|s 2024-01-21
|t 2
|w 2013-02-10
|y BK
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_GIB
|7 0
|9 21935
|a BRACUL
|b BRACUL
|c GEN
|d 2013-02-10
|e Karim International
|g 638.00
|l 5
|m 83
|o 615.7 GIB
|p 3010026659
|r 2024-04-17
|s 2024-01-21
|t 3
|w 2013-02-10
|y BK
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_000000000000000__7_GIB
|7 0
|9 21936
|a PHR
|b PHR
|d 2013-02-10
|e Karim International
|g 638.00
|l 1
|m 14
|o 615.7 GIB
|p 3010026660
|r 2015-01-24
|s 2014-10-01
|t 4
|w 2013-02-10
|y BK
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_GIB
|7 0
|9 21937
|a BRACUL
|b BRACUL
|c GEN
|d 2013-02-10
|e Karim International
|g 638.00
|l 2
|m 30
|o 615.7 GIB
|p 3010026661
|r 2024-02-27
|s 2024-01-21
|t 5
|w 2013-02-10
|y BK
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_GIB
|7 0
|9 76846
|a PHR
|b PHR
|d 2024-10-31
|e Hye Trade International
|g 1248.00
|l 0
|o 615.7 GIB
|p 3010043657
|r 2024-10-31
|t 6
|v 1248.00
|w 2024-10-31
|y BK
|x Requisitioned by Dr. Hasina Jesmin for the course named-"Biopharmaceutics & Pharmacokinetics I and II (PHR 304 and PHR 313)".
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_GIB
|7 0
|9 76847
|a PHR
|b PHR
|d 2024-10-31
|e Hye Trade International
|g 1248.00
|l 0
|o 615.7 GIB
|p 3010043661
|r 2024-10-31
|t 10
|v 1248.00
|w 2024-10-31
|y BK
|x Requisitioned by Dr. Hasina Jesmin for the course named-"Biopharmaceutics & Pharmacokinetics I and II (PHR 304 and PHR 313)".
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_GIB
|7 0
|9 76848
|a PHR
|b PHR
|d 2024-10-31
|e Hye Trade International
|g 1248.00
|l 0
|o 615.7 GIB
|p 3010043659
|r 2024-10-31
|t 8
|v 1248.00
|w 2024-10-31
|y BK
|x Requisitioned by Dr. Hasina Jesmin for the course named-"Biopharmaceutics & Pharmacokinetics I and II (PHR 304 and PHR 313)".
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_GIB
|7 0
|9 76849
|a PHR
|b PHR
|d 2024-10-31
|e Hye Trade International
|g 1248.00
|l 0
|o 615.7 GIB
|p 3010043660
|r 2024-10-31
|t 9
|v 1248.00
|w 2024-10-31
|y BK
|x Requisitioned by Dr. Hasina Jesmin for the course named-"Biopharmaceutics & Pharmacokinetics I and II (PHR 304 and PHR 313)".
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_GIB
|7 0
|9 76850
|a PHR
|b PHR
|d 2024-10-31
|e Hye Trade International
|g 1248.00
|l 0
|o 615.7 GIB
|p 3010043658
|r 2024-10-31
|t 7
|v 1248.00
|w 2024-10-31
|y BK
|x Requisitioned by Dr. Hasina Jesmin for the course named-"Biopharmaceutics & Pharmacokinetics I and II (PHR 304 and PHR 313)".
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_GIB
|7 0
|9 76853
|a BRACUL
|b BRACUL
|c GEN
|d 2024-10-31
|e Hye Trade International
|g 1248.00
|l 0
|o 615.7 GIB
|p 3010043682
|r 2024-10-31
|t 11
|v 1248.00
|w 2024-10-31
|y BK
|x Requisitioned by Dr. Hasina Jesmin for the course named-"Biopharmaceutics & Pharmacokinetics I and II (PHR 304 and PHR 313)".
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_GIB
|7 0
|9 76854
|a BRACUL
|b BRACUL
|c GEN
|d 2024-10-31
|e Hye Trade International
|g 1248.00
|l 0
|o 615.7 GIB
|p 3010043685
|r 2024-10-31
|t 14
|v 1248.00
|w 2024-10-31
|y BK
|x Requisitioned by Dr. Hasina Jesmin for the course named-"Biopharmaceutics & Pharmacokinetics I and II (PHR 304 and PHR 313)".
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_GIB
|7 0
|9 76855
|a BRACUL
|b BRACUL
|c GEN
|d 2024-10-31
|e Hye Trade International
|g 1248.00
|l 0
|o 615.7 GIB
|p 3010043687
|r 2024-10-31
|t 16
|v 1248.00
|w 2024-10-31
|y BK
|x Requisitioned by Dr. Hasina Jesmin for the course named-"Biopharmaceutics & Pharmacokinetics I and II (PHR 304 and PHR 313)".
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_GIB
|7 0
|9 76856
|a BRACUL
|b BRACUL
|c GEN
|d 2024-10-31
|e Hye Trade International
|g 1248.00
|l 0
|o 615.7 GIB
|p 3010043684
|r 2024-10-31
|t 13
|v 1248.00
|w 2024-10-31
|y BK
|x Requisitioned by Dr. Hasina Jesmin for the course named-"Biopharmaceutics & Pharmacokinetics I and II (PHR 304 and PHR 313)".
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_GIB
|7 0
|9 76857
|a BRACUL
|b BRACUL
|c GEN
|d 2024-10-31
|e Hye Trade International
|g 1248.00
|l 0
|o 615.7 GIB
|p 3010043686
|r 2024-10-31
|t 15
|v 1248.00
|w 2024-10-31
|y BK
|x Requisitioned by Dr. Hasina Jesmin for the course named-"Biopharmaceutics & Pharmacokinetics I and II (PHR 304 and PHR 313)".
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_GIB
|7 0
|9 76858
|a BRACUL
|b BRACUL
|c GEN
|d 2024-10-31
|e Hye Trade International
|g 1248.00
|l 0
|o 615.7 GIB
|p 3010043683
|r 2024-10-31
|t 12
|v 1248.00
|w 2024-10-31
|y BK
|x Requisitioned by Dr. Hasina Jesmin for the course named-"Biopharmaceutics & Pharmacokinetics I and II (PHR 304 and PHR 313)".
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_GIB
|7 0
|9 76898
|a BRACUL
|b BRACUL
|c GEN
|d 2024-11-19
|e Hye Trade International
|g 1248.00
|l 0
|o 615.7 GIB
|p 3010043790
|r 2024-12-04
|t 18
|v 1248.00
|w 2024-11-19
|y BK
|x Requisitioned by Dr. Hasina Jesmin for the course named-"Biopharmaceutics & Pharmacokinetics I and II (PHR 304 and PHR 313)".
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_GIB
|7 0
|9 76899
|a BRACUL
|b BRACUL
|c GEN
|d 2024-11-19
|e Hye Trade International
|g 1248.00
|l 0
|o 615.7 GIB
|p 3010043789
|r 2024-12-04
|t 17
|v 1248.00
|w 2024-11-19
|y BK
|x Requisitioned by Dr. Hasina Jesmin for the course named-"Biopharmaceutics & Pharmacokinetics I and II (PHR 304 and PHR 313)".
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_GIB
|7 0
|9 76900
|a BRACUL
|b BRACUL
|c GEN
|d 2024-11-19
|e Hye Trade International
|g 1248.00
|l 0
|o 615.7 GIB
|p 3010043792
|r 2024-12-04
|t 20
|v 1248.00
|w 2024-11-19
|y BK
|x Requisitioned by Dr. Hasina Jesmin for the course named-"Biopharmaceutics & Pharmacokinetics I and II (PHR 304 and PHR 313)".
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 615_700000000000000_GIB
|7 0
|9 76901
|a BRACUL
|b BRACUL
|c GEN
|d 2024-11-19
|e Hye Trade International
|g 1248.00
|l 0
|o 615.7 GIB
|p 3010043791
|r 2024-12-04
|t 19
|v 1248.00
|w 2024-11-19
|y BK
|x Requisitioned by Dr. Hasina Jesmin for the course named-"Biopharmaceutics & Pharmacokinetics I and II (PHR 304 and PHR 313)".
|